心力衰竭与心脏性休克的脱补偿表现出明显的顺序性炎症概况
Darshan H Brahmbhatt1,2,3,4, Fernando Luis Scolari1,2,3,5, Nicole L Fung1
1Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
ESC heart failure
|February 10, 2025
概括
带有心脏性休克 (ADHF-CS) 的急性不补偿性心力衰竭显示出高的炎症性细胞因子和白细胞计数. 这些炎症变化可能表明心力衰竭脱补偿的不同阶段,有助于风险识别.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 心肌梗塞后的心脏性休克 (CS) 影响患者的治疗结果.
- 在急性不补偿性心力衰竭 (ADHF-CS) 中,CS 的炎症特征尚不清楚.
- 研究ADHF-CS中的炎症标志物对于了解疾病进展至关重要.
研究的目的:
- 测量和比较ADHF-CS患者的炎症性细胞因子水平.
- 为了确定ADHF-CS,前CS和稳定的心力衰竭 (HF) 患者之间的炎症概况的差异.
- 探索炎症变化在预测CS风险方面的潜力.
主要方法:
- 确定了患有ADHF-CS的心脏重症监护病房 (CICU) 的患者.
- 对照组包括稳定HF的门诊患者和那些发展了CS (前CS) 的患者.
- 生物样本被分析为48复数细胞因子水平和白细胞差异.
主要成果:
- 与稳定的HF患者相比,ADHF-CS患者的炎症促细胞因子水平 (IL-1,IL-6,IL-8) 和总白细胞计数显著提高.
- 前CS组表现出中间的炎症特征,表明过渡期.
- 细胞因子档案清楚地区分了ADHF-CS和稳定的HF队列.
结论:
- ADHF-CS与增加的促炎性细胞因子和相对于门诊性高血压相对增加的白细胞计数有关.
- 心力衰竭失补偿可能涉及两个不同的炎症阶段.
- 识别这些炎症阶段可以帮助分层出风险患上CS的门诊患者.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
86
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86
01:24Blood Pressure Imbalances and Circulatory Shock
736
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
736
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374